Crossmark

Diflunisal targets the <scp>HMGB</scp> 1/ <scp>CXCL</scp> 12 heterocomplex and blocks immune cell recruitment

Crossref DOI link: https://doi.org/10.15252/embr.201947788

Published Online: 2019-08-14

Published Print: 2019-10-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

De Leo, Federica

Quilici, Giacomo

Tirone, Mario

De Marchis, Francesco

Mannella, Valeria

Zucchelli, Chiara

Preti, Alessandro

Gori, Alessandro

Casalgrandi, Maura

Mezzapelle, Rosanna

Bianchi, Marco E

Musco, Giovanna https://orcid.org/0000-0002-0469-2994
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (IG‐21440)

Associazione Italiana per la Ricerca sul Cancro (IG‐18623)
License Information

Version of Record valid from 2019-08-14
More Information

Publication History

Received: 2019-01-25

Accepted: 2019-07-23

Published: 2019-08-14